Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Clostridioides Difficile Infection: full-pipeline trial registry
5 of 7 indexed Clostridioides Difficile Infection trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Clostridioides Difficile Infection: 7 US clinical trials tracked, 5 recruiting.
Clostridioides Difficile Infection is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Vedanta Biosciences, running 1 of these trials.
Enrollment posture brief
Registry condition clostridioides-difficile-infection
OPEN 5 | RECR 71% | LATE 2 | EARLY 3 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Clostridioides Difficile Infection lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Clostridioides Difficile Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Clostridioides Difficile Infection is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Clostridioides Difficile Infection trials is spread across many organizations.
Vedanta Biosciences accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Clostridioides Difficile Infection enrolment sits around 260 participants.
Median target enrolment is 260 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.
-
Clostridioides Difficile Infection research is mostly interventional.
6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences
NCT06237452
LMN-201 for Prevention of C. Difficile Infection Recurrence
Lumen Bioscience
NCT05330182
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
University of Virginia
NCT04305769
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
AstraZeneca
NCT07285213
Evaluation of GeoHAI Implementation
Ohio State University
NCT05612672
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Summit Therapeutics
NCT03595553
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
Mayo Clinic
NCT04675723
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Clostridioides Difficile Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Clostridioides Difficile Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Clostridioides Difficile Infection page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Clostridioides Difficile Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Vedanta Biosciences sponsors the most Clostridioides Difficile Infection trials on record, review their full trial history before evaluating a specific study. See Vedanta Biosciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Clostridioides Difficile Infection condition card totals 7 registered trials; most-linked intervention Ridinilazole; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.